A New Trade Framework for Global Healthcare R&D
Open Access
- 17 February 2004
- journal article
- essay
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 2 (2) , e52
- https://doi.org/10.1371/journal.pbio.0020052
Abstract
Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives.Keywords
This publication has 7 references indexed in Scilit:
- Why PLoS Became a PublisherPLoS Biology, 2003
- Information Feudalism: Who Owns the Knowledge Economy?Contemporary Sociology: A Journal of Reviews, 2003
- Raiding the medicine cabinetNature, 2003
- Drive for patent-free innovation gathers paceNature, 2003
- Drugs for neglected diseases: a failure of the market and a public health failure?Tropical Medicine & International Health, 2001
- Rewards versus Intellectual Property RightsThe Journal of Law and Economics, 2001
- Patent Buyouts: A Mechanism for Encouraging InnovationThe Quarterly Journal of Economics, 1998